We are live on ! Find out more
VAM

Veritas Asset Management Portfolio holdings

AUM $5.56B
1-Year Est. Return 3.46%
This Fund
S&P 500
This Quarter Est. Return
-15.93%
1 Year Est. Return
+3.46%
3 Year Est. Return
+32.15%
5 Year Est. Return
+25.81%
10 Year Est. Return
+225.06%
AUM
$13.4B
AUM Growth
-$2.93B
Cap. Flow
-$230M
Cap. Flow %
-1.72%
Top 10 Hldgs %
67.02%
Holding
38
New
3
Increased
6
Reduced
27
Closed
–

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$399M
2
ILMN icon
Illumina
ILMN
+$247M
3
COO icon
Cooper Companies
COO
+$173M
4
AMZN icon
Amazon
AMZN
+$75.8M
5
EMBC icon
Embecta
EMBC
+$14.5M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$600M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$106M
3
CSGP icon
CoStar Group
CSGP
+$70.5M
4
BAX icon
Baxter International
BAX
+$64.4M
5
BDX icon
Becton Dickinson
BDX
+$56.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.66%
2 Communication Services 24.48%
3 Technology 11.65%
4 Industrials 8.9%
5 Financials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GD icon
26
General Dynamics
GD
$104B
$14.1M 0.11%
63,843
-23,557
-27% -$5.42M
EMBC icon
27
Embecta
EMBC
$212M
$12.8M 0.1%
+504,684
New +$14.5M
MDT icon
28
Medtronic
MDT
$110B
$10.9M 0.08%
121,946
-21,854
-15% -$2.21M
KO icon
29
Coca-Cola
KO
$374B
$9.23M 0.07%
146,684
-68,316
-32% -$4.33M
HDB icon
30
HDFC Bank
HDB
$122B
$8.62M 0.06%
313,632
-140,000
-31% -$3.95M
INFY icon
31
Infosys
INFY
$50.5B
$4.81M 0.04%
260,000
+60,000
+30% +$1.19M
CPNG icon
32
Coupang
CPNG
$28.7B
$1.91M 0.01%
150,000
– –
IBN icon
33
ICICI Bank
IBN
$109B
$1.77M 0.01%
100,000
– –
ABT icon
34
Abbott
ABT
$183B
$380K ﹤0.01%
3,500
-400
-10% -$45.4K
CTVA icon
35
Corteva
CTVA
$52.5B
$330K ﹤0.01%
6,100
-1,000
-14% -$58.1K
TSM icon
36
TSMC
TSM
$2.15T
$302K ﹤0.01%
+3,700
New +$342K
SBUX icon
37
Starbucks
SBUX
$121B
$275K ﹤0.01%
3,600
-800
-18% -$61.4K
NFLX icon
38
Netflix
NFLX
$309B
$262K ﹤0.01%
15,000
-7,000
-32% -$155K
1
2

Similar funds

DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Veritas Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Veritas Asset Management held 38 positions worth $13.4B, down 18% from $16.3B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Veritas Asset Management's Q2 2022 filing shows 3 new, 6 increased and 27 reduced positions. Its largest new stake was Bio-Rad Laboratories Class A: 766,762 shares worth $380M. The largest sale was CVS Health, an estimated $600M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 37% a quarter earlier, followed by Communication Services and Technology.

  • Veritas Asset Management's largest Q2 2022 buy was Bio-Rad Laboratories Class A: 766,762 shares worth $380M.
  • Veritas Asset Management added most to Illumina in Q2 2022, an estimated $247M increase.
  • Veritas Asset Management's biggest Q2 2022 reduction was CVS Health, cutting an estimated $600M.
  • Veritas Asset Management's ten largest holdings make up 67% of its $13.4B portfolio in Q2 2022.
  • Veritas Asset Management opened 3 new positions and closed 0 in Q2 2022.
  • Veritas Asset Management's portfolio value fell 18% quarter-over-quarter to $13.4B.

Based on Veritas Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.